Subscribe to RSS
DOI: 10.1055/a-1339-8683
GTH 2021: ACROSS BORDERS
![](https://www.thieme-connect.de/media/10.1055-s-00034925/202101/lookinside/thumbnails/10-1055-a-1339-8683_200095-1.jpg)
“Bienvenue!”, “Benvenuti!”, “Willkommen!”, “Welcome!” to the GTH 2021 congress, simply online … worth experiencing. During the Opening Ceremony, which will take place on Monday, February 22, you will enjoy, among other inspiring presentations (check on www.gth2021.org), the Alexander Schmidt Lecture held by the Awardee Markus Bender. The corresponding manuscript by Bender and Palankar,[1] masterfully summarizing recent findings on the contribution of the actin cytoskeleton and lamellipodia structures to platelet function, opens this year's congress issue of Hämostaseologie – Progress in Haemostasis.
Publication History
Received: 21 December 2020
Accepted: 21 December 2020
Article published online:
15 February 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Bender M, Palankar R. Platelet shape changes during thrombus formation: the role of actin-based protrusions. Hamostaseologie 2021; 41 (01) 14-21
- 2 Vivien D. New opportunities for diagnosis and prognosis of stroke: the benefit of across border approaches. Hamostaseologie 2021; 41 (01) 22-24
- 3 Chen J, Reheman A, Gushiken FC. et al. N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice. J Clin Invest 2011; 121 (02) 593-603
- 4 Aguiar de Sousa D. Cerebral venous thrombosis – What's new?. Hamostaseologie 2021; 41 (01) 25-30
- 5 De Marchis GM. DOAC after ischemic stroke: Which patient? Which drug? And how early?. Hamostaseologie 2021; 41 (01) 31-34
- 6 Beyer-Westendorf J. DOAC in atrial arrhythmias: current state of the art. Hamostaseologie 2021; 41 (01) 35-41
- 7 Blondon M. Screening for cancer in patients with acute venous thromboembolic disease. Hamostaseologie 2021; 41 (01) 42-47
- 8 Falanga A, Marchetti M, Schieppati F. Revention and management of thrombosis in BCR/ABL-negative myeloproliferative neoplasms. Hamostaseologie 2021; 41 (01) 48-56
- 9 Clarke RJ, Mayo G, Price P, FitzGerald GA. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin. N Engl J Med 1991; 325 (16) 1137-1141
- 10 Pascale S, Petrucci G, Dragani A. et al. Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target. Blood 2012; 119 (15) 3595-3603
- 11 Ranta L, Scala E. The perioperative management of heparin-induced thrombocytopenia. Hamostaseologie 2021; 41 (01) 57-60
- 12 Lillicrap D, Rawley O. Functional roles of the von Willebrand factor propeptide. Hamostaseologie 2021; 41 (01) 61-66
- 13 Longstaff C. Measuring fibrinolysis. Hamostaseologie 2021; 41 (01) 67-73
- 14 Scharf RE. How the COVID-19 pandemic impacts lives of life scientists. Hamostaseologie 2021; 41 (01) 9-12